drugset / Trial / NCT03009513
Teneligliptin-Glimepiride DDI Study
NaSingle-groupOpen-labelTreatment
Summary
An open label, one sequence study to investigate the pharmacokinetic drug interaction between Teneligliptin and Glimepiride in healthy male subjects
Timeline
- Start
- 2017-01
- Primary completion
- 2017-05
- Completion
- 2017-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Glimepiride | Small molecule | — | — |
| Subject | Teneligliptin | Small molecule | — | — |